Stock Analysis | Mondelez Outlook - Mixed Signals Amid Analyst Disagreement and Fundamental Strength

Market Snapshot

Takeaway: Mondelez (MDLZ) is facing a challenging technical outlook with a weak trend score of 3.9, but fundamental indicators are showing strength with an internal diagnostic score of 9.14.

News Highlights

Recent news affecting Mondelez includes:

• B&G Foods Sells the Le Sueur Brand to McCall Farms (August 1, 2025): This deal may shift market dynamics in the branded food sector, potentially affecting Mondelez's competitive landscape.
• Trump Admin to Revoke Dozens of Food Product Standards (July 17, 2025): The FDA's decision to eliminate outdated food standards could reduce regulatory burdens for companies like Mondelez, potentially improving operational flexibility.
• Brazil Negotiates with U.S. to Exclude Food Products from 50% Tariff (July 30, 2025): If successful, this could ease trade pressures on Mondelez's international operations and reduce potential cost increases.

Analyst Views & Fundamentals

Analysts are divided on Mondelez, with a simple average rating score of 3.86 and a performance-weighted rating of 2.22, reflecting a generally neutral to bearish outlook. This contrasts with the stock's recent 7.91% price decline, suggesting some alignment with market sentiment.

Key Fundamental Values and Model Scores:

• Net profit / Total profit: 73.24% (Internal diagnostic score: 8.72)
• Annualized return on equity: 7.85% (Internal diagnostic score: 9.14)
• Inventory turnover days: 61.10 (Internal diagnostic score: 8.94)
• Net income / Revenue: -20.61% (Internal diagnostic score: 9.43)
• Net assets per share growth rate: -92.96% (Internal diagnostic score: 7.62)

Money-Flow Trends

Mondelez is experiencing a negative overall trend in fund flows, with large and extra-large investors showing a negative direction. However, retail investors (small and medium) are showing a positive trend, with over 50% of inflows coming from these groups. This suggests a mixed sentiment between institutional and retail investors, with the former being more cautious.

Key Technical Signals

Mondelez's technical indicators paint a mixed picture, with more bearish than bullish signals:

• Earnings Release Date: Internal diagnostic score: 7.60 — A strong positive signal expected around July 29.
• MACD Death Cross: Internal diagnostic score: 3.72 — A bearish signal observed on July 30.
• WR Overbought: Internal diagnostic score: 1.15 — A bearish signal seen on July 24 and 25.
• WR Oversold: Internal diagnostic score: 3.26 — A mixed signal observed on July 30 and 31.

Recent Chart Patterns (July 24 to August 1):

• July 24-25: WR Overbought
• July 29: Earnings Release Date
• July 30-31: WR Oversold and MACD Death Cross

Key Insights: The technical analysis highlights a weak trend with 4 bearish indicators and 1 bullish indicator, suggesting caution for traders and investors.

Conclusion

Mondelez is in a mixed technical environment, with bearish signals outweighing bullish ones. However, the fundamental outlook is strong with an internal diagnostic score of 9.14. Investors should watch the upcoming earnings report (July 29) and monitor the impact of regulatory changes in the food sector. Given the technical weakness and analyst disagreement, it may be prudent to consider waiting for a clearer trend before making a move.